JPRN-UMIN000022988已完成未知
Combination therapy of intravitreal aflibercept and topical bromfenac for RVO - Combination therapy of IVA and bromfenac
Juntendo Urayasu Hospital0 个研究点目标入组 40 人开始时间: 2016年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The patient who has difficulty in periodical going to hospital. 2)The patients who have had vitrectomy surgery or anti-VEGF injection. 3)The patient who received intraocular operation within three months before first injection. 4)The patient that it was judged to be inappropriate as an object of this study. 5)The patients who had other disease which induce visual disorder.
研究者
相似试验
尚未招募
3 期
To investigate the role of Intravitreal Aflibercept (Eylea) in the treatment of patients whose wet Age related Macular degeneration is not adequately controlled with conventional anti VEGF (intravitreal Avastin or Lucentis) treatment.ACTRN12613001020774Greenlane Clinical Centre Auckland District Health Board50
已完成
4 期
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
已完成
不适用
Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularizatioSubfoveal type 2 choroidal neovascularizationJPRN-UMIN000016870agoya City University Graduate School of Medicine20
招募中
不适用
Treat and extend regimens with intravitreal aflibercept for macular edema secondary to branch retinal vein occlusiobranch retinal vein occlusionJPRN-UMIN000027005Jikei daisan hospital50
尚未招募
不适用
Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Corticosteroid for Macular EdemaKCT0007766Hallym University Medical Center-Kangnam188